Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HERSHEY COHSY · Entity 795 | Director | April 01, 2021 | April 05, 2021 |
| PITNEY BOWES INC /DE/PBI · Entity 4392 | Director | April 28, 2023 | May 01, 2023 |
| Teladoc Health, Inc.TDOC · Entity 1547 | Director | May 20, 2026 | May 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HERSHEY CO
Report date April 01, 2021 · Filed April 05, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,342.0986 |
Reported balance
After 2021-04-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-04-01 · Grant · Acquired 129.623 · Balance 16,342.0986 F1: The total amount of securities reported as directly owned in Column 5 includes 84.2015 shares acquired on March15, 2021, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The total amount of securities reported as directly owned in Column 5 includes 84.2015 shares acquired on March15, 2021, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders.
PITNEY BOWES INC /DE/
Report date April 28, 2023 · Filed May 01, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 134,802.9519 |
Reported balance
After 2023-04-28 transaction · row 1
1 source rowRow 1 · 2023-04-28 · Grant · Acquired 19,802 · Balance 134,802.9519 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-04-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-04-28 · Exercise / conversion · Disposed 19,802 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Pitney Bowes stock. F2: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will cliff vest 100% in one year (as defined in the Amended and Restated Pitney Bowes Inc. 2018 Stock Plan). |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Pitney Bowes stock.
F2: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will cliff vest 100% in one year (as defined in the Amended and Restated Pitney Bowes Inc. 2018 Stock Plan).
Teladoc Health, Inc.
Report date May 20, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 61,266 |
Reported balance
After 2026-05-20 transaction · row 1
1 source rowRow 1 · 2026-05-20 · Exercise / conversion · Acquired 29,986 · Balance 61,266 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-20 · Exercise / conversion · Disposed 28,986 · Balance 0 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F2: On May 22, 2025, the reporting person was granted 28,986 restricted stock units, vesting in full on May 20, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 30,441 |
Reported balance
After 2026-05-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-21 · Grant · Acquired 30,441 · Balance 30,441 F3: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F4: The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: On May 22, 2025, the reporting person was granted 28,986 restricted stock units, vesting in full on May 20, 2026.
F3: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F4: The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PFIZER INC
Report date December 31, 2007 · Filed January 03, 2008
Section 16 reporting ended · disclosed 2008-01-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock Units SSPSEC Table II · derivative / convertible security | Direct | 97,933 |
Reported balance
After 2007-12-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2007-12-31 · Grant · Acquired 384 · Balance 97,933 F1: Each unit represents one phantom share of common stock. F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. |
Filing footnotes · ownership attribution and instrument terms
F1: Each unit represents one phantom share of common stock.
F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2026 Filed May 21, 2026 21:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 30,441 | $0.00 | $0.00 |
DisclosureSEC source: 0001174459-26-000002 · wk-form4_1779398014.xml · derivative · entry 3 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,441 Underlying: Common Stock · 30,441 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F4 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. F4 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. Read SEC document |
| May 20, 2026 Filed May 21, 2026 21:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 28,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001174459-26-000002 · wk-form4_1779398014.xml · derivative · entry 2 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,986 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F2 · derivative.exercise_date: On May 22, 2025, the reporting person was granted 28,986 restricted stock units, vesting in full on May 20, 2026. F2 · derivative.expiration_date: On May 22, 2025, the reporting person was granted 28,986 restricted stock units, vesting in full on May 20, 2026. Read SEC document |
| May 20, 2026 Filed May 21, 2026 21:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 29,986 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001174459-26-000002 · wk-form4_1779398014.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 22, 2025 Filed May 23, 2025 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 28,986 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000065 · wk-form4_1748030749.xml · derivative · entry 3 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,986 Underlying: Common Stock · 28,986 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F4 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 22, 2026 and (ii) the day immediately preceding the issuer's 2026 annual meeting of stockholders. F4 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 22, 2026 and (ii) the day immediately preceding the issuer's 2026 annual meeting of stockholders. Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 17,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000065 · wk-form4_1748030749.xml · derivative · entry 2 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,467 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F2 · derivative.exercise_date: On May 23, 2024, the reporting person was granted 17,467 restricted stock units, vesting in full on May 21, 2025. F2 · derivative.expiration_date: On May 23, 2024, the reporting person was granted 17,467 restricted stock units, vesting in full on May 21, 2025. Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 17,467 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000065 · wk-form4_1748030749.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,280 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 23, 2024 Filed May 24, 2024 20:28 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 17,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000131 · wk-form4_1716582508.xml · derivative · entry 3 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,467 Underlying: Common Stock · 17,467 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F4 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 23, 2025 and (ii) the day immediately preceding the issuer's 2025 annual meeting of stockholders. F4 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 23, 2025 and (ii) the day immediately preceding the issuer's 2025 annual meeting of stockholders. Read SEC document |
| May 22, 2024 Filed May 24, 2024 20:28 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 9,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000131 · wk-form4_1716582508.xml · derivative · entry 2 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,834 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: On May 25, 2023, the reporting person was granted 9,834 restricted stock units, vesting in full on May 22, 2024. F3 · derivative.expiration_date: On May 25, 2023, the reporting person was granted 9,834 restricted stock units, vesting in full on May 22, 2024. Read SEC document |
| May 22, 2024 Filed May 24, 2024 20:28 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 9,834 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000131 · wk-form4_1716582508.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,813 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 25, 2023 Filed May 26, 2023 20:36 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 9,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-008859 · form4-05262023_080531.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,834 Underlying: Common Stock · 9,834 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 25, 2024 and (ii) the day immediately preceding the issuer's 2024 annual meeting of stockholders. F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 25, 2024 and (ii) the day immediately preceding the issuer's 2024 annual meeting of stockholders. Read SEC document |
| April 28, 2023 Filed May 1, 2023 20:30 UTC | PITNEY BOWES INC /DE/ PBI · Entity 4392 | Exercise / conversionRestricted Stock Units · Derivative | 19,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-003754 · primarydocument.xml · derivative · entry 2 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,802 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Pitney Bowes stock. F2 · derivative.exercise_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will cliff vest 100% in one year (as defined in the Amended and Restated Pitney Bowes Inc. 2018 Stock Plan). F2 · derivative.expiration_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will cliff vest 100% in one year (as defined in the Amended and Restated Pitney Bowes Inc. 2018 Stock Plan). Read SEC document |
| April 28, 2023 Filed May 1, 2023 20:30 UTC | PITNEY BOWES INC /DE/ PBI · Entity 4392 | GrantCommon Stock | 19,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-003754 · primarydocument.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,802.9519 Read SEC document |
| May 26, 2022 Filed May 31, 2022 20:15 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 6,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005895 · form4-05312022_010527.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,726 Underlying: Common Stock · 6,726 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 26, 2023 and (ii) the day immediately preceding the issuer's 2023 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 26, 2023 and (ii) the day immediately preceding the issuer's 2023 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. Read SEC document |
| May 02, 2022 Filed May 3, 2022 20:42 UTC | PITNEY BOWES INC /DE/ PBI · Entity 4392 | GrantRestricted Stock Units · Derivative | 19,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-003683 · primarydocument.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,700 Underlying: Common Stock · 19,802 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Pitney Bowes stock. F2 · derivative.exercise_date: The RSUs were granted on May 2, 2022 and have a one year (as defined in the Amended and Restated Pitney Bowes Inc. 2018 Stock Plan) cliff vesting. F2 · derivative.expiration_date: The RSUs were granted on May 2, 2022 and have a one year (as defined in the Amended and Restated Pitney Bowes Inc. 2018 Stock Plan) cliff vesting. Read SEC document |
| May 17, 2021 Filed May 18, 2021 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 1,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-005491 · edgar.xml · derivative · entry 3 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,638 Underlying: Common Stock · 1,638 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F4 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 17, 2022 and (ii) the day immediately preceding the issuer's 2022 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. F4 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 17, 2022 and (ii) the day immediately preceding the issuer's 2022 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-005491 · edgar.xml · derivative · entry 2 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,049 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: On May 28, 2020, the reporting person was granted 1,049 restricted stock units, vesting in full on May 17, 2021. F3 · derivative.expiration_date: On May 28, 2020, the reporting person was granted 1,049 restricted stock units, vesting in full on May 17, 2021. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,049 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-005491 · edgar.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 03, 2021 Filed May 4, 2021 18:15 UTC | PITNEY BOWES INC /DE/ PBI · Entity 4392 | GrantRestricted Stock Units · Derivative | 13,495 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-003127 · primarydocument.xml · derivative · entry 3 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,898 Underlying: Common Stock · 0 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Pitney Bowes stock. F3 · derivative.exercise_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will cliff vest 100% in one year. F3 · derivative.expiration_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will cliff vest 100% in one year. Read SEC document |
| April 30, 2021 Filed May 4, 2021 18:15 UTC | PITNEY BOWES INC /DE/ PBI · Entity 4392 | Exercise / conversionRestricted Stock Units · Derivative | 33,784 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-003127 · primarydocument.xml · derivative · entry 2 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,403 Underlying: Common Stock · 33,784 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Pitney Bowes stock. F2 · derivative.exercise_date: The RSUs were granted on May 4, 2020 and have a one year cliff vesting. F2 · derivative.expiration_date: The RSUs were granted on May 4, 2020 and have a one year cliff vesting. Read SEC document |
| April 30, 2021 Filed May 4, 2021 18:15 UTC | PITNEY BOWES INC /DE/ PBI · Entity 4392 | GrantCommon Stock | 33,784 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-003127 · primarydocument.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,481.2493 Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 14:14 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 129.623 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-012861 · form4.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,342.0986 F1 · ownership.direct: The total amount of securities reported as directly owned in Column 5 includes 84.2015 shares acquired on March15, 2021, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 18:37 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 264.148 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-000383 · form4.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,128.2741 F1 · ownership.direct: The total amount of securities reported as directly owned in Column 5 includes 84.3793 shares acquired on December 15, 2020, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 14:03 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 282.386 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026440 · form4.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,779.7468 F1 · ownership.direct: The total amount of securities reported as directly owned in Column 5 includes 84.213 shares acquired on September 15, 2020, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. Read SEC document |
| July 01, 2020 Filed Jul 1, 2020 18:40 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 313.259 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-020611 · form4.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,413.1478 F1 · ownership.direct: The total amount of securities reported as directly owned in Column 5 includes 89.7120 shares acquired on June 15, 2020, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 20:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 7,689 | $0.00 Strike: $30.50 | $0.00 |
DisclosureSEC source: 0001179110-20-007787 · edgar.xml · derivative · entry 5 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,689 shares Expires 2027-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in full on May 25, 2018. Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 20:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 1,438 | $0.00 Strike: $16.25 | $0.00 |
DisclosureSEC source: 0001179110-20-007787 · edgar.xml · derivative · entry 4 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,438 shares Expires 2026-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal annual installments beginning on November 1, 2017. Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 20:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 9,127 | $198.48 | $1,811,526.96 |
DisclosureSEC source: 0001179110-20-007787 · edgar.xml · nonDerivative · entry 3 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,930 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 20:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 7,689 | $30.50 | $234,514.50 |
DisclosureSEC source: 0001179110-20-007787 · edgar.xml · nonDerivative · entry 2 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 20:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,438 | $16.25 | $23,367.50 |
DisclosureSEC source: 0001179110-20-007787 · edgar.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,368 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 20:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 9,127 | $0.00 Strike: $16.25 | $0.00 |
DisclosureSEC source: 0001179110-20-007635 · edgar.xml · derivative · entry 3 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,438 Underlying: Common Stock · 9,127 shares Expires 2026-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal annual installments beginning on November 1, 2017. Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 20:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 9,127 | $189.00 | $1,725,003.00 |
DisclosureSEC source: 0001179110-20-007635 · edgar.xml · nonDerivative · entry 2 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,930 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 20:00 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 9,127 | $16.25 | $148,313.75 |
DisclosureSEC source: 0001179110-20-007635 · edgar.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2020 Filed Jun 12, 2020 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 9,127 | $0.00 Strike: $16.25 | $0.00 |
DisclosureSEC source: 0001179110-20-007260 · edgar.xml · derivative · entry 3 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,565 Underlying: Common Stock · 9,127 shares Expires 2026-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal annual installments beginning on November 1, 2017. Read SEC document |
| June 10, 2020 Filed Jun 12, 2020 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 9,127 | $170.00 | $1,551,590.00 |
DisclosureSEC source: 0001179110-20-007260 · edgar.xml · nonDerivative · entry 2 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,930 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| June 10, 2020 Filed Jun 12, 2020 20:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 9,127 | $16.25 | $148,313.75 |
DisclosureSEC source: 0001179110-20-007260 · edgar.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 20:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionStock Option (right to buy) · Derivative | 9,128 | $0.00 Strike: $16.25 | $0.00 |
DisclosureSEC source: 0001179110-20-007005 · edgar.xml · derivative · entry 3 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,692 Underlying: Common Stock · 9,128 shares Expires 2026-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal annual installments beginning on November 1, 2017. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 20:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 9,128 | $166.79 | $1,522,459.12 |
DisclosureSEC source: 0001179110-20-007005 · edgar.xml · nonDerivative · entry 2 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,930 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 4, 2020. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 20:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 9,128 | $16.25 | $148,330.00 |
DisclosureSEC source: 0001179110-20-007005 · edgar.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,058 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 1,049 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-006744 · edgar.xml · derivative · entry 3 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,049 Underlying: Common Stock · 1,049 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F4 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 28, 2021 and (ii) the day immediately preceding the issuer's 2021 annual meeting of stockholders. F4 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 28, 2021 and (ii) the day immediately preceding the issuer's 2021 annual meeting of stockholders. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 3,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-006744 · edgar.xml · derivative · entry 2 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,012 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: On May 30, 2019, the reporting person was granted 3,012 restricted stock units, vesting in full on May 28, 2020. F3 · derivative.expiration_date: On May 30, 2019, the reporting person was granted 3,012 restricted stock units, vesting in full on May 28, 2020. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,012 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-20-006744 · edgar.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,930 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 04, 2020 Filed May 5, 2020 20:19 UTC | PITNEY BOWES INC /DE/ PBI · Entity 4392 | GrantRestricted Stock Units · Derivative | 33,784 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-003371 · primarydocument.xml · derivative · entry 3 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,187 Underlying: Common Stock · 33,784 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Pitney Bowes stock. F3 · derivative.exercise_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will cliff vest 100% in one year. F3 · derivative.expiration_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will cliff vest 100% in one year. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:19 UTC | PITNEY BOWES INC /DE/ PBI · Entity 4392 | Exercise / conversionRestricted Stock Units · Derivative | 17,301 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-003371 · primarydocument.xml · derivative · entry 2 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,403 Underlying: Common Stock · 17,301 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Pitney Bowes stock. F2 · derivative.exercise_date: The RSUs were granted on May 1, 2019 and have a one year cliff vesting. F2 · derivative.expiration_date: The RSUs were granted on May 1, 2019 and have a one year cliff vesting. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:19 UTC | PITNEY BOWES INC /DE/ PBI · Entity 4392 | GrantCommon Stock | 17,301 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-003371 · primarydocument.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,845.3796 Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 19:31 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 299.155 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-012649 · form4.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,010.1768 F1 · ownership.direct: The total amount of securities reported as directly owned in Column 5 includes 90.5372 shares acquired on March 16, 2020, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 17:34 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 271.85 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-000407 · form4.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,620.4846 F1 · ownership.direct: The total amount of securities reported as directly owned in Column 5 includes 73.9012 shares acquired on December 16, 2019, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 18:38 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 251.053 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-029658 · form4.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,274.7334 F1 · ownership.direct: The total amount of securities reported as directly owned in Column 5 includes 72.1262 shares acquired on September 13, 2019, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 17:25 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 288.426 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-023433 · form4.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,951.5542 F1 · ownership.direct: The total amount of securities reported as directly owned in Column 5 includes 70.8426 shares acquired on June 14, 2019, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 20:03 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 3,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-006977 · edgar.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,012 Underlying: Common Stock · 3,012 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the earlier of (i) May 30, 2020 and (ii) the day immediately preceding the issuer's 2020 annual meeting of stockholders. F2 · derivative.expiration_date: The restricted stock units vest in full on the earlier of (i) May 30, 2020 and (ii) the day immediately preceding the issuer's 2020 annual meeting of stockholders. Read SEC document |
| May 06, 2019 Filed May 7, 2019 16:50 UTC | PITNEY BOWES INC /DE/ PBI · Entity 4392 | GrantRestricted Stock Units · Derivative | 17,301 | $5.78 | $99,999.78 |
DisclosureSEC source: 0001562180-19-002670 · primarydocument.xml · derivative · entry 3 SHEDLARZ DAVID L · CIK 0001174459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,704 Underlying: Common Stock · 17,301 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Pitney Bowes stock. F3 · derivative.exercise_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will cliff vest 100% in one year. F3 · derivative.expiration_date: Each unit represents a contingent right to receive one share of Pitney Bowes common stock that will cliff vest 100% in one year. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.